-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Amgen, Raises Price Target to $340

Benzinga·07/07/2026 11:42:06
Listen to the news
Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $327 to $340.